Status:
UNKNOWN
Facial Demodicosis and Ocular Demodicosis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Demodex Infestation
Rosacea
Eligibility:
All Genders
20+ years
Brief Summary
To understand the association between facial demodicosis and ocular demodicosis, we plan to enroll patients with facial demodicosis, ocular demodicosis, or both, in order to analyze their clinical pre...
Detailed Description
Although facial demodicosis and ocular demodicosis are described in a variety of clinical presentations, the association between the two diagnoses is not clearly identified. Clinically, we plan to en...
Eligibility Criteria
Inclusion
- Patient with a diagnosis of facial demodicosis or ocular demodicosis.
- A. Facial demodicosis defined as both 1 and 2:
- Clinical presentation of facial skin matches any of the followings:
- Pityriasis folliculorum.
- Papulopustular lesion.
- Rosacea.
- Demodex infestation detected by direct microscopic examination ≥ 5 mites/cm2.
- B. Ocular demodicosis defined as both 3 and 4:
- Clinical presentation of ocular region matches any of the followings:
- Chronic blepharitis.
- Eyelash abnormalities: trichiasis, distichiasis, madarosis.
- Meibomian gland dysfunction.
- Recurrent chalazion.
- Ocular rosacea.
- Demodex infestation detected by cilia epilation test ≥ 1 mite/eyelid.
Exclusion
- Usage of oral Ivermectin, topical Ivermectin or topical tea tree oil in the past 1 month.
- Patient who cannot tolerate direct microscopic examination or cilia epilation test.
Key Trial Info
Start Date :
April 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 14 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04377841
Start Date
April 13 2020
End Date
December 14 2020
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100229